New cancer vaccine trial offers hope for Tough-to-Treat lung tumors
NCT ID NCT05886439
Summary
This early-stage study is testing whether a new vaccine called LK101 can help control advanced lung cancer when given alongside existing immunotherapy drugs. The trial is for patients whose cancer has continued to grow despite previous immunotherapy treatments. Researchers will check if the combination is safe and if it can shrink tumors or slow their progression.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cancer hospital Chinese Academy of Medical Sciences
RECRUITINGBeijing, Beijing Municipality, 100021, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.